Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

Blood Lead Levels in Females of Childbearing Age in Flint, Michigan, and the Water Crisis.

Gómez HF, Borgialli DA, Sharman M, Weber AT, Scolpino AJ, Oleske JM, Bogden JD.

Obstet Gynecol. 2019 Sep;134(3):628-635. doi: 10.1097/AOG.0000000000003416.

PMID:
31403597
2.

A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries.

Cotton MF, Rabie H, Nemes E, Mujuru H, Bobat R, Njau B, Violari A, Mave V, Mitchell C, Oleske J, Zimmer B, Varghese G, Pahwa S; P1073 team.

PLoS One. 2019 Jul 1;14(7):e0211155. doi: 10.1371/journal.pone.0211155. eCollection 2019.

3.

A Guide to Build a Highly Inclined Swept Tile Microscope for Extended Field-of-view Single-molecule Imaging.

Tang J, Weng CH, Oleske JB, Han KY.

J Vis Exp. 2019 Apr 8;(146). doi: 10.3791/59360.

PMID:
31009011
4.

Analysis of blood lead levels of young children in Flint, Michigan before and during the 18-month switch to Flint River water.

Gómez HF, Borgialli DA, Sharman M, Shah KK, Scolpino AJ, Oleske JM, Bogden JD.

Clin Toxicol (Phila). 2019 Sep;57(9):790-797. doi: 10.1080/15563650.2018.1552003. Epub 2019 Mar 14.

PMID:
30871386
5.

Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.

Woerner A, Pourmalek F, Panozzo C, Pileggi G, Hudson M, Caric A, Abraham S, Varricchio F, Velasco C, Oleske J, Bauwens J, Bonhoeffer J; Brighton Collaboration Acute Aseptic Arthritis Working Group.

Vaccine. 2019 Jan 7;37(2):384-391. doi: 10.1016/j.vaccine.2017.08.087. Epub 2018 Oct 17. Review. No abstract available.

PMID:
30342899
6.

Blood Lead Levels of Children in Flint, Michigan: 2006-2016.

Gómez HF, Borgialli DA, Sharman M, Shah KK, Scolpino AJ, Oleske JM, Bogden JD.

J Pediatr. 2018 Jun;197:158-164. doi: 10.1016/j.jpeds.2017.12.063. Epub 2018 Mar 26.

PMID:
29599069
7.

The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.

Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Slogrove AL, Schomaker M, Davies MA, Williams P, Balkan S, Ben-Farhat J, Calles N, Chokephaibulkit K, Duff C, Eboua TF, Kekitiinwa-Rukyalekere A, Maxwell N, Pinto J, Seage G 3rd, Teasdale CA, Wanless S, Warszawski J, Wools-Kaloustian K, Yotebieng M, Timmerman V, Collins IJ, Goodall R, Smith C, Patel K, Paul M, Gibb D, Vreeman R, Abrams EJ, Hazra R, Van Dyke R, Bekker LG, Mofenson L, Vicari M, Essajee S, Penazzato M, Anabwani G, Q Mohapi E, N Kazembe P, Hlatshwayo M, Lumumba M, Goetghebuer T, Thorne C, Galli L, van Rossum A, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaia L, Rojo P, Fortuny C, Naver L, Rudin C, Le Coeur S, Volokha A, Rouzier V, Succi R, Sohn A, Kariminia A, Edmonds A, Lelo P, Ayaya S, Ongwen P, Jefferys LF, Phiri S, Mubiana-Mbewe M, Sawry S, Renner L, Sylla M, Abzug MJ, Levin M, Oleske J, Chernoff M, Traite S, Purswani M, Chadwick EG, Judd A, Leroy V.

PLoS Med. 2018 Mar 1;15(3):e1002514. doi: 10.1371/journal.pmed.1002514. eCollection 2018 Mar.

8.

Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.

DeSilva M, Munoz FM, Sell E, Marshall H, Tse Kawai A, Kachikis A, Heath P, Klein NP, Oleske JM, Jehan F, Spiegel H, Nesin M, Tagbo BN, Shrestha A, Cutland CL, Eckert LO, Kochhar S, Bardají A; Brighton Collaboration Congenital Microcephaly Working Group.

Vaccine. 2017 Dec 4;35(48 Pt A):6472-6482. doi: 10.1016/j.vaccine.2017.01.044. No abstract available.

9.

Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Neilan AM, Karalius B, Patel K, Van Dyke RB, Abzug MJ, Agwu AL, Williams PL, Purswani M, Kacanek D, Oleske JM, Burchett SK, Wiznia A, Chernoff M, Seage GR 3rd, Ciaranello AL; Pediatric HIV/AIDS Cohort Study and the International Maternal Adolescent and Pediatric AIDS Clinical Trials Network.

JAMA Pediatr. 2017 May 1;171(5):450-460. doi: 10.1001/jamapediatrics.2017.0141.

10.

Blood Lead Concentrations of Children in the United States: A Comparison of States Using Two Very Large Databases.

Shah KK, Oleske JM, Gomez HF, Davidow AL, Bogden JD.

J Pediatr. 2017 Jun;185:218-223. doi: 10.1016/j.jpeds.2017.01.059. Epub 2017 Feb 28.

PMID:
28258736
11.

Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.

Vergnano S, Buttery J, Cailes B, Chandrasekaran R, Chiappini E, Clark E, Cutland C, de Andrade SD, Esteves-Jaramillo A, Guinazu JR, Jones C, Kampmann B, King J, Kochhar S, Macdonald N, Mangili A, de Menezes Martins R, Velasco Muñoz C, Padula M, Muñoz FM, Oleske J, Sanicas M, Schlaudecker E, Spiegel H, Subelj M, Sukumaran L, Tagbo BN, Top KA, Tran D, Heath PT; Brighton Collaboration Neonatal Infections Working Group.

Vaccine. 2016 Dec 1;34(49):6038-6046. doi: 10.1016/j.vaccine.2016.03.046. Epub 2016 Aug 1.

12.

Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.

Jones CE, Munoz FM, Spiegel HM, Heininger U, Zuber PL, Edwards KM, Lambach P, Neels P, Kohl KS, Gidudu J, Hirschfeld S, Oleske JM, Khuri-Bulos N, Bauwens J, Eckert LO, Kochhar S, Bonhoeffer J, Heath PT; Brighton Collaboration Immunization in Pregnancy Working Group.

Vaccine. 2016 Dec 1;34(49):5998-6006. doi: 10.1016/j.vaccine.2016.07.032. Epub 2016 Jul 29.

13.

Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection.

Camacho-Gonzalez AF, Chernoff MC, Williams PL, Chahroudi A, Oleske JM, Traite S, Chakraborty R, Purswani MU, Abzug MJ; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1074 Study Team.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e22-e29. doi: 10.1093/jpids/piw039.

14.

Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data.

Rath B, Gidudu JF, Anyoti H, Bollweg B, Caubel P, Chen YH, Cornblath D, Fernandopulle R, Fries L, Galama J, Gibbs N, Grilli G, Grogan P, Hartmann K, Heininger U, Hudson MJ, Izurieta HS, Jevaji I, Johnson WM, Jones J, Keller-Stanislawski B, Klein J, Kohl K, Kokotis P, Li Y, Linder T, Oleske J, Richard G, Shafshak T, Vajdy M, Wong V, Sejvar J; Brighton Collaboration Bell's Palsy Working Group.

Vaccine. 2017 Apr 4;35(15):1972-1983. doi: 10.1016/j.vaccine.2016.05.023. Epub 2016 May 24. No abstract available.

PMID:
27235092
15.

Lessons for Flint's Officials and Parents From Our 1970s Newark Lead Program.

Oleske JM, Bogden JD.

Am J Public Health. 2016 Jun;106(6):e1. doi: 10.2105/AJPH.2016.303149. No abstract available.

16.

Stimulant Medications and Cognition, Behavior and Quality of Life in Children and Youth with HIV.

Sirois PA, Aaron L, Montepiedra G, Pearson DA, Kapetanovic S, Williams PL, Garvie PA, Nozyce ML, Malee K, Nichols SL, Kammerer BL, Mitchell WG, Mintz M, Oleske JM; IMPAACTPACTG 219C Team.

Pediatr Infect Dis J. 2016 Jan;35(1):e12-8. doi: 10.1097/INF.0000000000000947.

17.

Identifying Raman and Infrared Vibrational Motions of Erythritol Tetranitrate.

Oleske JB, Smith BT, Barber J, Weatherall JC.

Appl Spectrosc. 2015 Dec;69(12):1397-402. doi: 10.1366/14-07684.

PMID:
26647149
18.

Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.

Mirani G, Williams PL, Chernoff M, Abzug MJ, Levin MJ, Seage GR 3rd, Oleske JM, Purswani MU, Hazra R, Traite S, Zimmer B, Van Dyke RB; IMPAACT P1074 Study Team.

Clin Infect Dis. 2015 Dec 15;61(12):1850-61. doi: 10.1093/cid/civ687. Epub 2015 Aug 12.

19.

Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.

Krogstad P, Patel K, Karalius B, Hazra R, Abzug MJ, Oleske J, Seage GR 3rd, Williams PL, Borkowsky W, Wiznia A, Pinto J, Van Dyke RB; Pediatric HIVAIDS Cohort Study, IMPAACT 219C, and NICHD International Site Development Initiative (NISDI) Investigators.

AIDS. 2015 Mar 27;29(6):683-93. doi: 10.1097/QAD.0000000000000598.

20.

Early viral suppression improves neurocognitive outcomes in HIV-infected children.

Crowell CS, Huo Y, Tassiopoulos K, Malee KM, Yogev R, Hazra R, Rutstein RM, Nichols SL, Smith RA, Williams PL, Oleske J, Muller WJ; PACTG 219C Study Team and the Pediatric HIVAIDS Cohort Study (PHACS).

AIDS. 2015 Jan 28;29(3):295-304. doi: 10.1097/QAD.0000000000000528.

21.

Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infection.

Mitchell CD, Chernoff MC, Seage GR 3rd, Purswani MU, Spiegel HM, Zilleruelo G, Abitbol C, Heckman B, Ponce CB, Oleske JM; IMPAACT 219/219C Study Team.

Pediatr Nephrol. 2015 Jan;30(1):153-65. doi: 10.1007/s00467-014-2909-1. Epub 2014 Aug 24.

22.

Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment.

Williams PL, Abzug MJ, Jacobson DL, Wang J, Van Dyke RB, Hazra R, Patel K, Dimeglio LA, McFarland EJ, Silio M, Borkowsky W, Seage GR 3rd, Oleske JM, Geffner ME; International Maternal Pediatric and Adolescent AIDS Clinical Trials P219219C Study and the Pediatric HIVAIDS Cohort Study.

AIDS. 2013 Jul 31;27(12):1959-70. doi: 10.1097/QAD.0b013e328361195b.

23.

The Greater Metropolitan Medical Alumni Council (GMMAC): the realization of a need.

Belilos E, Oleske JM, Medow NB, Sadovsky R, Campese CL, Bello JA, Swan KG.

J Investig Med. 2013 Aug;61(6):967-71. doi: 10.2310/JIM.0b013e318297d249.

PMID:
23736685
24.

Central Nervous System Vasculopathy in HIV-Infected Children Enrolled in the Pediatric AIDS Clinical Trials Group 219/219C Study.

Schieffelin JS, Williams PL, Djokic D, Anderson JP, Nachman S, Oleske JM, Seage GR 3rd, Van Dyke RB.

J Pediatric Infect Dis Soc. 2013 Mar;2(1):50-6. doi: 10.1093/jpids/pis095. Epub 2012 Oct 26.

PMID:
26619442
25.

Slit ventricle syndrome: a case report of intermittent intracranial hypertension.

Agarwal N, Vernier E, Ravenscroft S, Schwartz L, Oleske J, Ming X.

J Child Neurol. 2013 Jun;28(6):784-6. doi: 10.1177/0883073812449906. Epub 2012 Jul 17.

PMID:
22805245
26.

The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.

Patel K, Van Dyke RB, Mittleman MA, Colan SD, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219219C Study Team.

AIDS. 2012 Oct 23;26(16):2027-37. doi: 10.1097/QAD.0b013e3283578bfa.

27.

Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Gidudu JF, Walco GA, Taddio A, Zempsky WT, Halperin SA, Calugar A, Gibbs NA, Hennig R, Jovancevic M, Netterlid E, O'Connor T, Oleske JM, Varricchio F, Tsai TF, Seifert H, Schuind AE; Brighton Immunization Site Pain Working Group.

Vaccine. 2012 Jun 22;30(30):4558-77. doi: 10.1016/j.vaccine.2012.03.085. Epub 2012 Apr 18. No abstract available.

PMID:
22521267
28.

Chronic kidney disease associated with perinatal HIV infection in children and adolescents.

Purswani MU, Chernoff MC, Mitchell CD, Seage GR 3rd, Zilleruelo G, Abitbol C, Andiman WA, Kaiser KA, Spiegel H, Oleske JM; IMPAACT 219/219C Study Team.

Pediatr Nephrol. 2012 Jun;27(6):981-9. doi: 10.1007/s00467-011-2097-1. Epub 2012 Feb 26.

29.

Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV.

Kapetanovic S, Aaron L, Williams PL, Farley J, Sirois PA, Garvie PA, Pearson DA, Oleske JM, Montepiedra G; The IMPAACT PACTG 219C Team.

Neurobehav HIV Med. 2010 Aug;2010(2):39-48.

30.

Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M; Brighton Collaboration GBS Working Group.

Vaccine. 2011 Jan 10;29(3):599-612. doi: 10.1016/j.vaccine.2010.06.003. Epub 2010 Jun 18. Review. No abstract available.

PMID:
20600491
31.

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Brogly SB, Abzug MJ, Watts DH, Cunningham CK, Williams PL, Oleske J, Conway D, Sperling RS, Spiegel H, Van Dyke RB.

Pediatr Infect Dis J. 2010 Aug;29(8):721-7. doi: 10.1097/INF.0b013e3181e74a2f.

32.

Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.

Crain MJ, Chernoff MC, Oleske JM, Brogly SB, Malee KM, Borum PR, Meyer WA 3rd, Mitchell WG, Moye JH, Ford-Chatterton HM, Van Dyke RB, Seage Iii GR.

J Infect Dis. 2010 Jul 15;202(2):291-301. doi: 10.1086/653497.

33.

Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.

Brady MT, Oleske JM, Williams PL, Elgie C, Mofenson LM, Dankner WM, Van Dyke RB; Pediatric AIDS Clinical Trials Group219/219C Team.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):86-94. doi: 10.1097/QAI.0b013e3181b9869f.

34.

The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.

Kapetanovic S, Aaron L, Montepiedra G, Sirois PA, Oleske JM, Malee K, Pearson DA, Nichols SL, Garvie PA, Farley J, Nozyce ML, Mintz M, Williams PL; Pediatric AIDS Clinical Trials.

AIDS Patient Care STDS. 2009 Nov;23(11):939-47. doi: 10.1089/apc.2009.0121.

35.

Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.

Sirois PA, Montepiedra G, Kapetanovic S, Williams PL, Pearson DA, Malee K, Garvie PA, Kammerer BL, Nichols SL, Nozyce ML, Mintz M, Mitchell WG, Oleske JM; IMPAACT/PACTG 219C Team.

J Dev Behav Pediatr. 2009 Oct;30(5):403-12.

36.

Standoff detection of nitrotoluenes using 213-nm amplified spontaneous emission from nitric oxide.

Arnold B, Kelly L, Oleske JB, Schill A.

Anal Bioanal Chem. 2009 Sep;395(2):349-55. doi: 10.1007/s00216-009-2990-7. Epub 2009 Aug 1.

PMID:
19649618
37.

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.

Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team.

AIDS. 2009 Sep 10;23(14):1893-901. doi: 10.1097/QAD.0b013e32832dc041.

38.

Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.

Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM, Currier JS, Gallant JE; HIV Medicine Association of the Infectious Diseases Society of America.

Clin Infect Dis. 2009 Sep 1;49(5):651-81. doi: 10.1086/605292.

PMID:
19640227
39.

Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors.

Andiman WA, Chernoff MC, Mitchell C, Purswani M, Oleske J, Williams PL, Spiegel H, Gona P, Seage GR 3rd; PACTG iDACS 617 Study Team.

Pediatr Infect Dis J. 2009 Jul;28(7):619-25. doi: 10.1097/INF.0b013e31819ca49a.

40.

Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus.

Winter HS, Oleske JM, Hughes MD, McKinney RE Jr, Elgie C, Powell C, Purdue L, Puga AM, Jimenez E, Scott GB, Cruz ML, Moye J Jr; Pediatric AIDS Clinical Trials Group Protocol 247 Study Team.

J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):222-32. doi: 10.1097/MPG.0b013e3181928937.

41.

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.

Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd, Oleske J, Williams PL; PACTG 219C Team.

Arch Pediatr Adolesc Med. 2009 Feb;163(2):164-71. doi: 10.1001/archpedi.163.2.164. Erratum in: Arch Pediatr Adolesc Med. 2009 Apr;163(4):364.

42.

Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study.

Williams PL, Van Dyke R, Eagle M, Smith D, Vincent C, Ciupak G, Oleske J, Seage GR 3rd; PACTG 219C Team.

Am J Epidemiol. 2008 Jun 1;167(11):1375-86. doi: 10.1093/aje/kwn072. Epub 2008 Apr 15.

43.

Do-not-resuscitate orders and/or hospice care, psychological health, and quality of life among children/adolescents with acquired immune deficiency syndrome.

Lyon ME, Williams PL, Woods ER, Hutton N, Butler AM, Sibinga E, Brady MT, Oleske JM.

J Palliat Med. 2008 Apr;11(3):459-69. doi: 10.1089/jpm.2007.0148.

44.

Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Tassiopoulos K, Williams PL, Seage GR 3rd, Crain M, Oleske J, Farley J; International Maternal Pediatric Adolescent AIDS Clinical Trials 219C Team.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):607-14. doi: 10.1097/QAI.0b013e3181648e16.

45.

All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization.

Rath B, Linder T, Cornblath D, Hudson M, Fernandopulle R, Hartmann K, Heininger U, Izurieta H, Killion L, Kokotis P, Oleske J, Vajdy M, Wong V; Brighton Collaboration Bell's Palsy Working Group.

Vaccine. 2007 Dec 21;26(1):1-14. Epub 2007 Nov 8. Review.

PMID:
18037542
46.

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Sejvar JJ, Kohl KS, Bilynsky R, Blumberg D, Cvetkovich T, Galama J, Gidudu J, Katikaneni L, Khuri-Bulos N, Oleske J, Tapiainen T, Wiznitzer M; Brighton Collaboration Encephalitis Working Group.

Vaccine. 2007 Aug 1;25(31):5771-92. Epub 2007 May 11. No abstract available.

PMID:
17570566
47.

Inadvertent inoculation as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Wenger P, Oleske JM, Kohl KS, Fisher MC, Brien JH, Graham PL, LaRussa PS, Lipton S, Tierney B; Brighton Collaboration Vaccinia Virus Adverse Event Working Group for Inadvertent Inoculation.

Vaccine. 2007 Aug 1;25(31):5754-62. Epub 2007 May 4. No abstract available.

PMID:
17537553
48.

Reproductive health of adolescent girls perinatally infected with HIV.

Brogly SB, Watts DH, Ylitalo N, Franco EL, Seage GR 3rd, Oleske J, Eagle M, Van Dyke R.

Am J Public Health. 2007 Jun;97(6):1047-52. Epub 2007 Apr 26.

49.

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.

Brogly SB, Ylitalo N, Mofenson LM, Oleske J, Van Dyke R, Crain MJ, Abzug MJ, Brady M, Jean-Philippe P, Hughes MD, Seage GR 3rd.

AIDS. 2007 May 11;21(8):929-38.

PMID:
17457086
50.

Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Jones JF, Kohl KS, Ahmadipour N, Bleijenberg G, Buchwald D, Evengard B, Jason LA, Klimas NG, Lloyd A, McCleary K, Oleske JM, White PD; Brighton Collaboration Fatigue Working Group.

Vaccine. 2007 Aug 1;25(31):5685-96. Epub 2007 Mar 12. No abstract available.

PMID:
17400340

Supplemental Content

Loading ...
Support Center